Skip to Main Content

Paper Details

Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.
Cell Rep
119
2019
Author NameAffiliation
Graham MacLeodLeslie Dan Faculty of Pharmacy, University of Toronto
Zachary SteinhartLeslie Dan Faculty of Pharmacy, University of Toronto
Florence M G CavalliDevelopmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Traver HartThe University of Texas MD Anderson Cancer Center
Peter B DirksDevelopmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto
Stephane AngersLeslie Dan Faculty of Pharmacy, University of Toronto
  • 1 - 6

Datasets

Release 1.2